Cannabis Use Disorder Diagnostic Criteria and Clinical Implications

Diagnostic Classification

The American Psychiatric Association recommends that Cannabis Use Disorder (CUD) mild requires meeting 2-3 criteria, while moderate requires 4-5 criteria, and severe requires 6 or more criteria 3
The American Psychiatric Association states that DSM-5 eliminated the distinction between abuse and dependence, combining them into a single disorder with severity specifiers 2, 3
The diagnostic threshold was set at 2+ criteria in DSM-5 to maintain similar prevalence rates to the combined DSM-IV abuse and dependence diagnoses, as recommended by the American Psychiatric Association 1

The American Psychiatric Association added "craving" as a new criterion for Cannabis Use Disorder in DSM-5 2
The American Psychiatric Association recognizes cannabis withdrawal as a syndrome in DSM-5, which was not included in DSM-IV 4, 5
The American Psychiatric Association removed the legal problems criterion that was present in DSM-IV Cannabis Abuse 6

The American Psychiatric Association approach better represents the dimensional nature of cannabis problems, as factor analyses showed criteria formed one factor rather than two separate disorders 6
The mild CUD designation identifies patients at an earlier stage who might benefit from intervention, particularly in primary care settings, according to the American Psychiatric Association 1

Cannabis withdrawal was not recognized in DSM-IV but is included in DSM-5 based on accumulated evidence, as stated by the American Psychiatric Association 4, 5
Common withdrawal symptoms include irritability, anxiety, sleep disturbances, decreased appetite, restlessness, altered mood, and physical discomfort, with symptoms typically occurring within 3 days after cessation and may last up to 14 days 7, 8

Approximately 10% of adults with chronic cannabis use may develop cannabis use disorder, with early onset of cannabis use strongly predicting future dependence 8, 9
Long-standing cannabis use can lead to cannabinoid hyperemesis syndrome, characterized by cyclical emetic episodes relieved by hot showers 8

Tolerance and withdrawal in patients using cannabis for supervised medical purposes should not count toward a CUD diagnosis when no other criteria are met, as recommended by the American Psychiatric Association 1, 3
Clinicians should avoid using stigmatizing language when discussing cannabis use with patients, and be aware that cannabis use may exacerbate psychiatric disorders in vulnerable individuals, complicating diagnosis and treatment 8, 9